Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Clinical Trials ETF

48.54
-1.3991-2.80%
Post-market: 48.570.0302+0.06%19:30 EDT
Volume:19.43K
Turnover:941.16K
Market Cap:46.11M
PE:- -
High:49.48
Open:49.46
Low:48.06
Close:49.94
52wk High:56.18
52wk Low:23.81
Shares:950.00K
Float Shares:950.00K
Volume Ratio:1.17
T/O Rate:2.05%
Dividend:0.65
Dividend Rate:1.35%
ROE:--
ROA:--
PB:1.04
PE(LYR):- -

Loading ...

From Subsidized Weapons to Deep Gun Culture Love: Why Does Thailand Keep Experiencing Tragic School Shootings?

Deep News
·
Aug 08

AbCellera to Report Phase 2 Menopause Therapy Data

TIPRANKS
·
Aug 08

The BBC shouldn’t push Londoners to accept antisocial phone behaviour

cityam
·
Aug 07

BBC to broadcast Alexis Ohanian co-founded all-female athletics series Athlos

cityam
·
Aug 07

These New Drugs Could Fuel Fresh Highs for Biotech and Pharma Stocks

Dow Jones
·
Aug 07

Black Diamond Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

GlobeNewswire
·
Aug 06

Moderna announces initiation of Phase 1 trial of mRNA-1469

TIPRANKS
·
Aug 04

US President Remarks on Air Force One, Says ABC is Worse Than BBC After Learning Reporter's Affiliation

Deep News
·
Aug 03

Essential Morning Digest: Key Stories You Shouldn't Miss

Deep News
·
Aug 03

Hugging Face CEO Says AI Firms Must Be Held Accountable for Rogue Bot Attacks

MT Newswires Live
·
Aug 01

Thalia Therapeutics Updates Voting Rights as RNA Therapy Pipeline Advances

TIPRANKS
·
Jul 31

GSK Advances New Toddler Pneumococcal Booster, Signaling Ongoing Vaccine Pipeline Momentum

TIPRANKS
·
Jul 31

Moderna Targets Ebola With New mRNA Vaccine Trial: What Investors Should Watch

TIPRANKS
·
Jul 31

Biophytis Publishes 2025 Accounts as Trading Resumes Amid Going-Concern Doubts

TIPRANKS
·
Jul 30

Grifols says EXCELL Phase 3 trial timeline not ‘new development or a delay’

TIPRANKS
·
Jul 30

Zealand Pharma’s New Psoriasis Trial Sets Early Stage for ZP9830

TIPRANKS
·
Jul 30

Racura Advances HARNESS-1 Trial After Safe First-Patient Treatment With RC220 Combo

TIPRANKS
·
Jul 29

Atea Pharmaceuticals reports C-BEYOND trial meets primary, secondary endpoints

TIPRANKS
·
Jul 28

10 Monday AM Reads

The Big Picture
·
Jul 27

High-Speed Rail Linking Ningbo and Suzhou Reaches New Milestone

Deep News
·
Jul 27